UB Paderborn / Katalog / Suche / in CDI

Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects

Inflammation, 2016-02, Vol.39 (1), p.182-189

2016

Link zum Volltext

Verfügbarkeit prüfen

Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina

Journal of the American Heart Association, 2019-08, Vol.8 (15), p.e012811-e012811

2019

Link zum Volltext

Verfügbarkeit prüfen

Association Between Gout and Aortic Stenosis

The American journal of medicine, 2017-02, Vol.130 (2), p.230.e1-230.e8

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease

The New England journal of medicine, 2015-11, Vol.373 (20), p.1937-1946

2015

Link zum Volltext

Verfügbarkeit prüfen

Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial

Circulation Cardiovascular quality and outcomes, 2013-07, Vol.6 (4), p.409-418

2013

Link zum Volltext

Verfügbarkeit prüfen

Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout

Journal of rheumatology, 2012-07, Vol.39 (7), p.1458

2012

Link zum Volltext

Verfügbarkeit prüfen

Hyperglycemia in Nondiabetic Patients Presenting With Acute Myocardial Infarction

The American journal of the medical sciences, 2012-04, Vol.343 (4), p.321-326

2012

Link zum Volltext

Verfügbarkeit prüfen

Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction

Coronary artery disease, 2018-01, Vol.29 (1), p.46-52

2018

Link zum Volltext

Verfügbarkeit prüfen

Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia

JACC. Cardiovascular interventions, 2014-02, Vol.7 (2), p.195

2014

Link zum Volltext

Verfügbarkeit prüfen

Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial

Journal of the American College of Cardiology, 2018-11, Vol.72 (19), p.2297-2305

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program

The American journal of cardiology, 2022-10, Vol.180 (C), p.1-9

2022

Link zum Volltext

Verfügbarkeit prüfen

Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients: A Post-Hoc Analysis From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)

Journal of the American College of Cardiology, 2013-11, Vol.62 (20), p.1826-1833

2013

Link zum Volltext

Verfügbarkeit prüfen

Percutaneous coronary intervention: FAME is lasting

The Lancet (British edition), 2015-11, Vol.386 (10006), p.1806-1807

2015

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and Management of Type II Myocardial Infarction: Increased Demand for a Limited Supply of Evidence

Current atherosclerosis reports, 2015-02, Vol.17 (2), p.478-478, Article 4

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease

Current cardiology reports, 2017-02, Vol.19 (2), p.17-17, Article 17

2017

Link zum Volltext

Verfügbarkeit prüfen

The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial

Catheterization and cardiovascular interventions, 2016-11, Vol.88 (5), p.727-737

2016

Link zum Volltext

Verfügbarkeit prüfen

Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome

Current cardiology reports, 2016-08, Vol.18 (8), p.79-79, Article 79

2016

Link zum Volltext

Verfügbarkeit prüfen

Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial

Journal of the American College of Cardiology, 2010-03, Vol.55 (13), p.1348-1358

2010

Link zum Volltext

Verfügbarkeit prüfen

Glycemic Control in Coronary Revascularization

Current treatment options in cardiovascular medicine, 2016-02, Vol.18 (2), p.12-12, Article 12

2016

Link zum Volltext

Verfügbarkeit prüfen

Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease: A Pre-Specified Subset Analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) Trial

Journal of the American College of Cardiology, 2009-09, Vol.54 (14), p.1303-1308

2009

Link zum Volltext

Verfügbarkeit prüfen

Moderate Doses of hGH (0.64 mg/d) Improve Lipids But Not Cardiovascular Function in GH-Deficient Adults with Normal Baseline Cardiac Function

The journal of clinical endocrinology and metabolism, 2011-01, Vol.96 (1), p.122-132

2011

Link zum Volltext

Verfügbarkeit prüfen

Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy: Observations From the COURAGE Trial

Circulation. Cardiovascular interventions, 2011-12, Vol.4 (6), p.545-552

2011

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects

Inflammation, 2016-02, Vol.39 (1), p.501-501

2016

Link zum Volltext

Verfügbarkeit prüfen

Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry)

The American journal of cardiology, 2004-07, Vol.94 (1), p.118-120

2004

Link zum Volltext

Verfügbarkeit prüfen

Avoiding stent thrombosis: advances in technique, antiplatelet pharmacotherapy and stent design

Interventional Cardiology, 2013-04, Vol.5 (2), p.179-201

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects

Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina

Association Between Gout and Aortic Stenosis

Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease

Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial

Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout

Hyperglycemia in Nondiabetic Patients Presenting With Acute Myocardial Infarction

Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction

Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia

Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial

Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program

Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients: A Post-Hoc Analysis From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)

Percutaneous coronary intervention: FAME is lasting

Diagnosis and Management of Type II Myocardial Infarction: Increased Demand for a Limited Supply of Evidence

Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease

The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial

Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome

Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial

Glycemic Control in Coronary Revascularization

Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease: A Pre-Specified Subset Analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) Trial

Moderate Doses of hGH (0.64 mg/d) Improve Lipids But Not Cardiovascular Function in GH-Deficient Adults with Normal Baseline Cardiac Function

Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy: Observations From the COURAGE Trial

Erratum to: Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects

Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry)

Avoiding stent thrombosis: advances in technique, antiplatelet pharmacotherapy and stent design

Aktive Filter

Suchergebnisse filtern